Dr. Sarah Noonberg is AbCellera's Chief Medical Officer and is responsible for advancing the company's clinical pipeline; she joined in 2025 and presents on the company's earnings calls. A board-certified physician-scientist with more than 20 years of experience leading development programs from discovery to commercialization, she was previously Chief Medical Officer of Metagenomi, Chief Medical Officer of Maze Therapeutics, Head of Global Clinical Development at BioMarin, and Senior Vice President at Medivation. She received her M.D. from the University of California, San Francisco, a Ph.D. in Bioengineering from the University of California, Berkeley, and a bachelor's degree in Engineering Sciences from Dartmouth College, and trained in internal medicine at Johns Hopkins Hospital. (Source: abcellera.com)